LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Search

Pfizer

Chiusa

SettoreSettore sanitario

24.9 -2.16

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

24.72

Massimo

25.49

Metriche Chiave

By Trading Economics

Entrata

623M

3.6B

Vendite

2B

17B

P/E

Media del settore

14.581

106.172

EPS

0.87

Rendimento da dividendi

6.78

Margine di Profitto

21.322

Dipendenti

81,000

EBITDA

325M

5.6B

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+14.26% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

6.78%

2.31%

Prossima data del Dividendo

1 dic 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2.4B

143B

Apertura precedente

27.06

Chiusura precedente

24.9

Notizie sul Sentiment di mercato

By Acuity

42%

58%

154 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Pfizer Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 nov 2025, 17:39 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Completes Acquisition of Metsera

10 nov 2025, 13:08 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

10 nov 2025, 09:41 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle

17 nov 2025, 18:20 UTC

Acquisizioni, Fusioni, Takeovers

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

14 nov 2025, 12:22 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Pharma Sector Becoming Bidding Battlefield -- Market Talk

13 nov 2025, 16:26 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer Completes Acquisition Of Metsera >PFE

10 nov 2025, 16:35 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Pfizer CEO Confident Metsera Therapies Will Get Approval -- Market Talk

10 nov 2025, 16:26 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Pfizer CEO: Metsera Has Exciting Weight-Loss Portfolio -- Market Talk

10 nov 2025, 15:36 UTC

Acquisizioni, Fusioni, Takeovers

What's Next for Novo Nordisk? -- WSJ

10 nov 2025, 14:05 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

10 nov 2025, 12:33 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 nov 2025, 12:32 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 nov 2025, 10:45 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

10 nov 2025, 10:34 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More -- Barrons.com

10 nov 2025, 10:32 UTC

Azioni calde

Stocks to Watch Monday: Metsera, Novo Nordisk, Nvidia, Tyson Foods -- WSJ

10 nov 2025, 09:26 UTC

Acquisizioni, Fusioni, Takeovers

Novo Nordisk Shares Rise After Withdrawal From Metsera Takeover Battle

8 nov 2025, 13:10 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov 2025, 03:50 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov 2025, 03:41 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov 2025, 03:07 UTC

Acquisizioni, Fusioni, Takeovers

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 nov 2025, 13:26 UTC

Acquisizioni, Fusioni, Takeovers

Correction to This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. Article -- WSJ

7 nov 2025, 10:30 UTC

Acquisizioni, Fusioni, Takeovers

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. -- WSJ

6 nov 2025, 20:02 UTC

Acquisizioni, Fusioni, Takeovers

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. -- Barrons.com

6 nov 2025, 16:16 UTC

Utili

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

6 nov 2025, 12:29 UTC

Utili

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 nov 2025, 12:15 UTC

Utili

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 nov 2025, 00:24 UTC

Acquisizioni, Fusioni, Takeovers

Metsera: Pfizer Has Reiterated It Will Continue to Litigate >MTSR

6 nov 2025, 00:24 UTC

Acquisizioni, Fusioni, Takeovers

Metsera: Board of Directors Will Continue to Stand Firm on Behalf of Shareholders, Patients >MTSR

6 nov 2025, 00:24 UTC

Acquisizioni, Fusioni, Takeovers

Metsera: Gratified by Court Decision to Deny Pfizer's Request for Temporary Restraining Order to Block Board From Acting in Shareholders' Best Interests >MTSR

6 nov 2025, 00:22 UTC

Acquisizioni, Fusioni, Takeovers

Metsera Issues Statement in Response to Pfizer Litigation Ruling

Confronto tra pari

Modifica del prezzo

Pfizer Previsione

Obiettivo di Prezzo

By TipRanks

14.26% in crescita

Previsioni per 12 mesi

Media 29.08 USD  14.26%

Alto 34 USD

Basso 24 USD

Basato su 15 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Pfizer - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

15 ratings

4

Acquista

10

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

22.855 / 23.85Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

154 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat